RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationPublic Consultation open on: ICH guideline Q14 on analytical procedure development
The European Medicines Agency has published ICH guideline Q2(R2) on validation of analytical procedures for public consultation.
In March FDA published 'An Acceptable Circular of Information for the Use of Human Blood and Blood Components' - Guidance for Industry
Medicines: get scientific advice from MHRA - New Email Address
This Roadmap Tool sets out the key steps and activities in the end-to-end pathway for Advanced Therapy Medicinal Products (ATMPs) in England from non-clinical research through to treatment provision & monitoring.
CTIS newsflash #07 - 18 March 2022
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 March 2022
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 March 2022
Delivering High Standards in Medicines Advertising Regulation, 2021 Annual Report
MHRA Webinar: Medicines Supply to Northern Ireland